Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk.
Journal: medRxiv : the preprint server for health sciences
Published: March 11, 2024
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 18, 2021
Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations.
Journal: Journal of the advanced practitioner in oncology
Published: July 01, 2019
The utility of patient reported data in a gynecologic oncology clinic.
Journal: Gynecologic oncology research and practice
Published: November 29, 2017
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 28, 2016
MRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability.
Journal: European journal of radiology
Published: June 17, 2016
Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 07, 2016
Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 28, 2014
Tubal origin of ovarian endometriosis.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 11, 2013
PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.
Journal: Journal of hematology & oncology
Published: July 18, 2013
Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.
Journal: Gynecologic oncology
Published: June 26, 2013
Last Updated: 09/26/2026